After RAS inhibitors: what comes next in pancreatic cancer?
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...
The main areas of research at the bench focus on finding biomarkers for early detection of the disease, on understanding the molecular mechanisms o...
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in...